Last quarter (Q ), Genocea Biosciences's total revenue was $270.00K, an increase of Infinity% from the same quarter last year. In Q, Genocea Biosciences's net income was $-15.98M. See Genocea Biosciences’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 21	Dec 20	Dec 19	Dec 18	Dec 17
Total Revenue	$ 1.91M	$ 1.64M	$ 1.36M	$ 0.00	$ 0.00	$ 0.00
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Expense	$ 57.35M	$ 53.73M	$ 48.35M	$ 38.99M	$ 39.52M	$ 52.64M
Operating Income	$ -55.44M	$ -52.09M	$ -46.99M	$ -38.99M	$ -39.52M	$ -52.64M
Net Non Operating Interest Income Expense	$ -1.07M	$ -1.12M	$ -1.38M	$ -946.00K	$ -1.02M	$ -1.44M
Other Income Expense	$ 19.33M	$ 20.02M	$ 4.66M	$ 985.00K	$ 12.73M	$ -2.63M
Pretax Income	$ -37.19M	$ -33.20M	$ -43.71M	$ -38.95M	$ -27.81M	$ -56.71M
Tax Provision	-	-	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -37.19M	$ -33.20M	$ -43.71M	$ -38.95M	$ -27.81M	$ -56.71M
Basic EPS	$ -0.52	$ -0.48	$ -0.98	$ -1.89	$ -2.69	$ -15.84
Diluted EPS	$ -0.66	$ -0.48	$ -1.11	$ -1.89	$ -2.69	$ -15.84
Basic Average Shares	$ 279.20M	$ 68.58M	$ 44.44M	$ 20.64M	$ 10.32M	$ 3.58M
Diluted Average Shares	$ 281.44M	$ 68.58M	$ 46.55M	$ 20.64M	$ 10.32M	$ 3.58M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 57.35M	$ 53.73M	$ 48.35M	$ 38.99M	$ 39.52M	$ 52.64M
Net Income From Continuing And Discontinued Operation	$ -37.19M	$ -33.20M	$ -43.71M	$ -38.95M	$ -27.81M	$ -56.71M
Normalized Income	$ -56.49M	$ -53.34M	$ -52.60M	$ -39.94M	$ -42.57M	$ -54.09M
Interest Expense	$ 1.07M	$ 1.12M	$ 1.38M	$ 946.00K	$ 1.02M	$ 1.44M
EBIT	$ -36.12M	$ -32.08M	$ -42.33M	$ -38.00M	$ -26.79M	$ -55.27M
EBITDA	$ -34.54M	$ -30.52M	$ -41.20M	$ -36.91M	$ -25.70M	$ -53.75M

Currency in USD

Genocea Biosciences Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing